Bulletin
Investor Alert

NextCure Inc.

NAS: NXTC

GO
/marketstate/country/us

After Hours

/zigman2/quotes/212182367/composite

$

9.50

Change

-0.07 -0.68%

Volume

Volume 4,451

Aug 7, 2020, 7:53 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/212182367/composite

Today's close

$ 9.59

$ 9.57

Change

-0.03 -0.26%

Day low

Day high

$9.28

$9.68

Open
Open: 9.49

52 week low

52 week high

$8.00

$109.00

Open

Market cap

$263.89M

Average volume

969,647

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.96

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nxtc

MarketWatch News on NXTC

  1. NextCure upgraded to buy from hold at Benchmark

    5:59 a.m. July 16, 2020

    - Tomi Kilgore

  2. NextCure downgraded to hold from buy at Benchmark

    6:10 a.m. June 1, 2020

    - Tomi Kilgore

  3. NextCure started at buy with $55 stock price target ta Benchmark

    6:27 a.m. March 24, 2020

    - Tomi Kilgore

  4. NextCure Stock Collapses After New Cancer Drug Data

    3:47 p.m. Nov. 11, 2019

    - Barron's Online

  5. NextCure started at overweight at Morgan Stanley

    11:05 a.m. June 3, 2019

    - Tomi Kilgore

/news/nonmarketwatch/company/us/nxtc

Other News on NXTC

  1. 10-Q: NEXTCURE, INC.

    4:24 p.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. A Stock-Picker's Guide To Benjamin Graham's Screening Rules

    5:46 a.m. Aug. 1, 2020

    - Seeking Alpha

  3. DELL, NAK among premarket gainers

    8:16 a.m. July 16, 2020

    - Seeking Alpha

  4. VXRT, ONCS, CLSN and FUV among midday movers

    12:43 p.m. July 13, 2020

    - Seeking Alpha

  5. NextCure launches mid-stage study of NC410 in solid tumors

    4:51 p.m. July 7, 2020

    - Seeking Alpha

  6. NextCure (NXTC) Investor Presentation - Slideshow

    1:33 p.m. May 29, 2020

    - Seeking Alpha

  7. NextCure (NXTC) Presents At ASCO 2020 - Slideshow

    1:33 p.m. May 29, 2020

    - Seeking Alpha

  8. NextCure delays launch of NC318 and NC410 trials amid COVID-19

    7:46 a.m. April 13, 2020

    - Seeking Alpha

  9. Why You Shouldn't Bet Against NextCure (NXTC) Stock

    8:52 a.m. March 26, 2020

    - Zacks.com

  10. Blair likes Incyte in premarket analyst action

    7:53 a.m. March 24, 2020

    - Seeking Alpha

  11. Cowen likes Amarin in premarket analyst action

    9:47 a.m. March 2, 2020

    - Seeking Alpha

  12. Stocks To Watch: Time For Coronavirus Offense Or Defense?

    9:26 a.m. Feb. 29, 2020

    - Seeking Alpha

  13. Stocks To Watch: Key 2020 Events And Catalysts

    9:22 a.m. Jan. 1, 2020

    - Seeking Alpha

  14. Best ETFs for 2020: Bet on Newly Public Companies With IPO ETF

    1:56 p.m. Dec. 11, 2019

    - InvestorPlace.com

  15. Loading more headlines...
/news/pressrelease/company/us/nxtc

Press Releases on NXTC

  1. NextCure Reports Second Quarter 2020 Financial Results

    4:03 p.m. Aug. 6, 2020

    - GlobeNewswire

  2. NextCure to Present at BTIG Virtual Biotechnology Conference

    8:05 a.m. Aug. 5, 2020

    - GlobeNewswire

  3. NextCure Reports First Quarter 2020 Financial Results

    5:11 p.m. May 7, 2020

    - GlobeNewswire

  4. NextCure Announces Closing of Public Offering

    5:05 p.m. Nov. 19, 2019

    - GlobeNewswire

  5. NextCure Announces Closing of Public Offering

    5:05 p.m. Nov. 19, 2019

    - GlobeNewswire

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.